Moderna delays Phase 3 trial for COVID-19 vaccine
Moderna’s heavily anticipated trial for a coronavirus vaccine, which was set to begin next week, has been delayed.
“Moderna has previously disclosed that the Phase 3 trial of its COVID-19 vaccine candidate mRNA-1273 is expected to begin in July. The trial is still expected to begin in July and we expect to be the first to start a Phase 3 trial,” read a company statement sent to The New York Daily News Thursday. “We have worked closely with NIH/OWS to align on the final protocol in order to begin the trial on time.”
The Phase 3 study, which includes 30,000 patients, was initially supposed to begin on July 9, but changes to the trial plan have altered the schedule, investigators who spoke anonymously told STAT earlier Thursday.
Although such changes are reportedly common, Moderna did not elaborate on what the particular alterations are.
“My understanding was that they wanted to get the first vaccines given in July, and they say they’re still committed to do that,” one of the investigators told the health and medicine publication. “As best I can tell, they’re close to being on target for that.”
Also on Thursday, Dr. Francis Collins, the Director of the National Institutes of Health, testified to lawmakers that Moderna is working with the National Institute of Allergy and Infectious Diseases and the Biomedical Advanced Research and Development Authority to launch the trial “as early as this month, pending positive results from this Phase 2 trial,” which began in late May.
Moderna isn’t the only horse in the race to develop and manufacture a COVID-19 vaccine.
Partnering with BioNTech, Pfizer’s own 30,000-patient study is slated to start this month. AstraZeneca and Oxford University have their own trial of similar proportions scheduled to begin in August, and Johnson & Johnson plans to start one in September.
©2020 New York Daily News
Visit New York Daily News at www.nydailynews.com
Distributed by Tribune Content Agency, LLC.
Stories that may interest you
New York’s attorney general is suing the National Rifle Association, seeking to put the powerful gun advocacy organization out of business over allegations that high-ranking executives diverted millions of dollars for personal benefit
A New York judge has knocked down President Donald Trump’s bid to delay a lawsuit from a woman who accused him of rape
Reopening schools during the coronavirus pandemic means putting children on school buses, and districts are working on plans to limit the risk
All of our stories about the coronavirus are being provided free of charge as a service to the public. You can find all of our stories here.